In‐vivo and in‐vitro models of type 2 diabetes in pharmaceutical drug discovery
1999; Wiley; Volume: 1; Issue: 2 Linguagem: Inglês
10.1046/j.1463-1326.1999.00014.x
ISSN1463-1326
AutoresMichael Reed, Karen A. Scribner,
Tópico(s)Regulation of Appetite and Obesity
ResumoDiabetes, Obesity and MetabolismVolume 1, Issue 2 p. 75-86 REVIEW ARTICLE In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery Michael J. Reed, Michael J. Reed Shaman Pharmaceuticals, Inc., South San Francisco, CA, USASearch for more papers by this authorKaren A. Scribner, Karen A. Scribner Shaman Pharmaceuticals, Inc., South San Francisco, CA, USASearch for more papers by this author Michael J. Reed, Michael J. Reed Shaman Pharmaceuticals, Inc., South San Francisco, CA, USASearch for more papers by this authorKaren A. Scribner, Karen A. Scribner Shaman Pharmaceuticals, Inc., South San Francisco, CA, USASearch for more papers by this author First published: 25 December 2001 https://doi.org/10.1046/j.1463-1326.1999.00014.xCitations: 31 Dr Michael J. Reed, 215 Durham Street, Menlo Park, CA 94025, USA.E-mail:losreeds@earthlink.net AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume1, Issue2March 1999Pages 75-86 RelatedInformation
Referência(s)